Who Is a Candidate for Lenire? What 2 Years of Fittings Taught Me
By Dr. Layne Garrett, Au.D., FAAA, ABAC, CH-TM, CDP
Published September 28, 2026
Some tinnitus patients try Lenire and say it changed their life. Others complete treatment and see much less improvement.
After two years of fitting Lenire — and more fittings than any other clinic in Utah — I’ve learned that candidacy matters enormously. Lenire is not a treatment I recommend simply because someone has tinnitus. The severity of the tinnitus, what treatment has already been tried, and whether someone can consistently follow the protocol all affect whether it makes sense.
This article walks through the same criteria I use when a patient asks me a simple question: “Am I actually a good candidate for Lenire?”
Lenire is generally intended for adults with at least moderate tinnitus burden who have been appropriately evaluated and are able to follow the treatment protocol consistently. A Tinnitus Handicap Inventory (THI) score of 38 or higher is an important candidacy threshold, but severity is only one part of the decision. We also look at what treatments you’ve already tried, whether hearing loss or other contributors have been addressed, and whether you can commit to the prescribed daily sessions. The best way to determine candidacy is through a comprehensive tinnitus evaluation rather than relying on tinnitus severity alone.
Table of Contents
- The Wrong Question — and the Right One
- How Lenire Works
- Who Responds — and Who Doesn’t
- When Lenire Doesn’t Work
- What This Means If You’re in Utah
- FAQ
The Wrong Question — and the Right One
Patients often ask me, “Does Lenire work?”
That is not really the most useful question.
The better question is: “Am I the kind of tinnitus patient Lenire was designed to help?”
Those are very different questions. Lenire has clinical evidence behind it, but that does not mean every person with tinnitus is a good candidate. The treatment requires a real commitment of time, money, and daily use, so candidacy matters before treatment ever begins.
A typical Lenire treatment course involves two 30-minute sessions each day for 12 weeks. If your tinnitus severity, treatment history, or ability to follow that protocol do not line up with the patients most likely to benefit, it is better to know that before making the investment.
That is why evidence-based tinnitus care should include an honest candidacy conversation.
Our job is not to convince every tinnitus patient to try Lenire. It is to determine whether Lenire fits into the treatment plan at all — and, if it does, whether now is the right time.
Timpanogos Hearing & Tinnitus is a Lenire Preferred Provider, which has given our team extensive experience evaluating, fitting, and following patients through the full treatment protocol. That experience has also made us more selective about who we recommend it for.
The rest of this article explains the criteria we use.
How Lenire Works
Lenire is a form of bimodal neuromodulation, meaning it uses two types of stimulation at the same time.
During treatment, the patient listens to calibrated sounds through headphones while receiving gentle electrical stimulation through a small tongue-tip device.
Those two inputs are designed to engage connected auditory and sensory pathways at the same time. The goal is not to mask tinnitus temporarily, but to encourage changes in how the nervous system processes the tinnitus signal over time.
That is also why candidacy matters.
Lenire is not simply another sound generator or hearing device. It is a structured neuroplasticity-based treatment, and the patients most likely to benefit are not necessarily everyone who happens to hear tinnitus.
If you want the deeper explanation of the mechanism, see our complete Lenire treatment guide or our article explaining how Lenire uses sound and tongue stimulation.
Who Responds — and Who Doesn’t
What I see in practice lines up closely with the published data: patients with a more significant tinnitus burden tend to have a better chance of meaningful improvement with Lenire than patients whose tinnitus scores in the mild range.
A 2025 real-world study published in Communications Medicine looked at patients treated with bimodal neuromodulation in a clinical setting and found substantial improvement among appropriately selected patients. A second 2025 study in the American Journal of Audiology reported similar real-world effectiveness.
That matches what I have seen over two years of Lenire fittings.
Patients with moderate or greater tinnitus burden are much more likely to report that tinnitus has become less intrusive, less distracting, and less dominant in daily life. That does not mean the tinnitus disappears, and it does not mean every well-selected patient responds the same way.
But patients with mild tinnitus tend to show much less change.
That distinction matters because Lenire is not simply a treatment for the presence of tinnitus. It is designed for patients whose tinnitus is creating a meaningful functional burden.
The pivotal TENT-A3 trial published in Nature Communications also found that combined sound and tongue stimulation provided greater benefit than sound stimulation alone in patients with moderate or worse tinnitus.
If you want the trial-by-trial details, I break them down in What the Research on Lenire Actually Shows — And Who It’s Right For.
The studies can tell us what tends to happen across groups of patients. They cannot tell us with certainty what will happen for one individual.
That is where candidacy assessment comes in.
The Three Filters I Use for Lenire Candidacy
When a patient asks whether Lenire is right for them, I work through three filters in order: severity, treatment sequence, and adherence.
None of them works particularly well in isolation. A high tinnitus score does not automatically make someone a good candidate, and someone who looks ideal on paper may still be a poor fit if they cannot realistically follow the treatment protocol.
Filter 1: Tinnitus Severity
Severity is the first screen.
Lenire candidacy uses the Tinnitus Handicap Inventory (THI), a validated questionnaire that measures how much tinnitus is interfering with everyday life. A THI score of 38 or higher — generally representing moderate or greater tinnitus burden — is an important threshold in determining whether Lenire should be considered.
That distinction matters because having tinnitus is not the same thing as having tinnitus severe enough to justify this particular treatment.
If the sound is present but is not significantly affecting sleep, concentration, emotional well-being, work, or daily function, Lenire may not be the right tool at that point.
Over two years of fittings, this is also one area where my own candidacy criteria have become more selective. Patients with a meaningful functional burden tend to be better candidates than patients near or below the severity threshold.
Filter 2: Where Lenire Fits in the Treatment Sequence
Lenire is not automatically the first treatment I recommend simply because someone has tinnitus.
Before considering bimodal neuromodulation, we need to understand the larger clinical picture. Is hearing loss present? Has it been appropriately treated? Have other tinnitus-management strategies been tried? Are there medical, somatic, or other contributors that still need to be addressed?
For many patients, those steps should come first.
Our complete Lenire treatment guide explains where bimodal neuromodulation fits within a broader tinnitus-treatment plan, and our review of what the Lenire research actually shows goes deeper into the patients who have benefited in published studies.
The point is not that everyone must exhaust every possible treatment before Lenire. It is that Lenire should fit into a rational treatment sequence rather than being treated as a shortcut around a proper tinnitus evaluation.
Filter 3: Can You Follow the Protocol?
This is the filter patients tend to underestimate.
The Lenire protocol requires two 30-minute sessions each day for approximately 12 weeks. Neuroplasticity depends on repeated, consistent stimulation, which means the treatment schedule is part of the treatment — not an optional recommendation.
I often compare it to physical therapy. If a rehabilitation program calls for daily exercises and you do them occasionally, you have not really completed the prescribed program.
The same principle applies here.
Before I recommend Lenire, I want to know whether a patient can realistically build those sessions into daily life for the full treatment period. If the answer is no, that matters just as much as the THI score.
The patients who do well are not simply the patients with the highest tinnitus scores. They are patients who are appropriately selected and who follow the treatment protocol consistently.
Where Does Your Tinnitus Fall?
Before Lenire candidacy can be considered, we first need to understand how much tinnitus is actually affecting your daily life. The short assessment below can help you get a clearer picture of your current tinnitus burden.
When Lenire Doesn’t Work
Lenire does not work equally well for every patient, and that is an important part of the candidacy conversation.
In my experience, poor outcomes are more common when one of two things is true: the patient was not a strong candidate in the first place, or the treatment protocol was not followed consistently.
The first problem is largely preventable.
If tinnitus severity is below the range where Lenire has shown meaningful benefit, recommending an expensive and time-intensive treatment does not make much sense. That is why we measure tinnitus burden before making a recommendation rather than relying on how loud the sound seems or how long someone has had it.
The second issue is adherence. Lenire depends on repeated stimulation over the prescribed treatment period. Missing sessions or stopping early can reduce the likelihood of getting the result the treatment was designed to produce.
But even when candidacy looks appropriate and the protocol is followed correctly, there are no guarantees.
Some patients complete the full treatment course and experience substantial improvement. Others improve more modestly, and a smaller number may see little meaningful change. Lenire is a treatment option — not a cure and not a certainty.
It also does not replace the rest of tinnitus care.
If hearing loss is present, it still needs to be addressed appropriately. Sound therapy, counseling strategies, CBT-based tinnitus support, and management of other contributing factors may still be part of the plan.
That is why we view Lenire as one component of a broader tinnitus-treatment strategy rather than a standalone answer. You can learn more about that approach in our complete guide to Lenire tinnitus treatment and our review of what the Lenire research actually shows.
The wrong patient should not be talked into Lenire. But an appropriate candidate should not be dismissed with “you just have to live with it,” either.
Lenire Evaluation in Utah: What to Expect at Our Clinics
If you have been researching Lenire and want a clear answer about whether you are actually a candidate, the first step is not buying the device. It is getting a comprehensive tinnitus evaluation.
At our American Fork, Spanish Fork, and South Jordan clinics, we evaluate tinnitus severity, hearing status, speech-in-noise ability, symptom history, and other possible contributing factors before recommending a treatment plan.
That evaluation helps answer three practical questions:
- Is your tinnitus burden significant enough for Lenire to be worth considering?
- Does Lenire make sense at this point in your treatment sequence?
- Can you realistically follow the treatment protocol consistently?
By the end of the evaluation, you should have a much clearer idea of where Lenire fits — or whether another treatment approach makes more sense first.
Timpanogos Hearing & Tinnitus has been recognized as Best of State in Auditory Services 15 times. Our tinnitus professionals hold advanced tinnitus credentials through organizations including the American Board of Audiology and the International Hearing Society, and our practice is a Lenire Preferred Provider with extensive experience evaluating and treating patients with bimodal neuromodulation.
If you want to understand the treatment itself before scheduling, start with our complete Lenire tinnitus treatment guide or read our review of what the Lenire research actually shows.
When You’re Ready to Find Out
Schedule a consultation and we’ll evaluate your tinnitus severity, review your history, and tell you objectively whether Lenire appears to be an appropriate next step.
You can also explore more tinnitus and Lenire resources in our Learning Center.
FAQ
Lenire is generally intended for adults with at least moderate tinnitus burden. A Tinnitus Handicap Inventory (THI) score of 38 or higher is an important candidacy threshold, but it is not the only factor we consider. Treatment history, hearing status, other possible contributors, and your ability to follow the daily protocol all matter too.
Usually not as the first step. Mild tinnitus can still be very distressing, but published data and our clinical experience suggest that patients in the mild range tend to see less benefit from Lenire than patients with moderate or greater tinnitus burden. In that situation, other approaches such as treating hearing loss, sound therapy, counseling strategies, or CBT-based tinnitus support may make more sense first.
Not with certainty. No clinician can guarantee how an individual patient will respond. But candidacy can be assessed much more intelligently by looking at tinnitus severity, where Lenire fits in the treatment sequence, and whether the patient can realistically complete the protocol as prescribed. That helps reduce the odds of recommending an expensive, time-intensive treatment to someone who is unlikely to benefit.
It can happen. Some patients complete the full protocol and improve only modestly or not enough to consider the treatment successful. In that situation, we reassess the overall tinnitus plan rather than assuming there is nothing else to do. Hearing treatment, sound therapy, counseling-based approaches, or other contributing factors may still need attention.
A typical treatment course involves two 30-minute sessions each day for approximately 12 weeks. Consistency matters because the treatment is designed around repeated stimulation over time. Missing sessions or stopping early can affect the likelihood of getting the intended benefit.
No. Hearing loss is not required for Lenire candidacy. However, hearing status is still an important part of a comprehensive tinnitus evaluation. If hearing loss is present and has not been appropriately addressed, that may affect where Lenire fits in the treatment plan.
Timpanogos Hearing & Tinnitus evaluates Lenire candidacy at our American Fork, Spanish Fork, and South Jordan locations. We are the only full-time Lenire provider in Northern Utah.
About the Author
Dr. Layne Garrett, Au.D., FAAA, ABAC, CH-TM, CDP is the founder of Timpanogos Hearing & Tinnitus, with clinic locations in American Fork, Spanish Fork, and South Jordan, Utah. Over 20 years, he has specialized in tinnitus management, helping thousands of patients along the Wasatch Front. Timpanogos Hearing & Tinnitus has been recognized as Best of State in Auditory Services 15 times and is one of only 14 Lenire Preferred Providers in the United States. His practice emphasizes patient education over sales-driven care.
Reviewed/Edited By:
Dr. Layne Garrett, Au.D., FAAA, ABAC, CH-TM, CDP
Date Reviewed/Edited:
June 28, 2026
